The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...

Kennedy Jr. accepted his new position as health secretary, he made a big show of distancing himself from his past life. Ne ...

The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include ...

FDA drug alerts in infectious diseases, including new drug approvals, safety warnings, recalls, and changes in indications.

A landmark global modeling study reveals that more than 2.8 billion people in 104 countries are at risk of chikungunya, with ...

The UK’s Medicines and Healthcare products Regulatory Agency said that following global reports of serious adverse events in ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

UK's medicine regulator said on Monday it has temporarily restricted the use of French vaccine maker Valneva's shot to treat ...

Critical voices on unfairly high mpox and other vaccine prices open the debate on the ‘right price’ to be paid to private vaccine suppliers. We apply compound real options analysis as a more ...

[Courtesy] Kenya’s progress in preventing childhood diseases like measles and rotavirus is at risk as donor support for vaccines phases out. As donor support dwindles ahead of 2029, Gavi ...

In April, the CDC’s vaccine advisers met after a two-month delay to vote on recommendations for chikungunya vaccines, meningitis vaccines and respiratory syncytial virus (RSV) vaccines.

The only product currently authorized for chikungunya vaccination is Ixchiq. In Réunion, the use of the Ixchiq vaccine has been restricted since late April to people aged 18 to 64 because of ...